HELIUS MEDICAL TECHNOLOGIES (HSDT)       0.273  +0.01 (+2.02%)

0.273  +0.01 (+2.02%)

US42328V6039 - Common Stock - After market: 0.275 +0 (+0.73%)

HELIUS MEDICAL TECHNOLOGIES0.273

NASDAQ:HSDT (12/9/2022, 7:00:02 PM)+0.01 (+2.02%)

After market: 0.275 +0 (+0.73%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Health Care Equipment & Supplies
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 11-14 2022-11-14/bmo Earnings (Next) 03-13 2023-03-13
Ins Owners 0.15% Inst Owners 2.9%
Market Cap 7.70M Shares 28.20M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 85
IPO 06-27 2014-06-27

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

HSDT Daily chart

Company Profile

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania. The company went IPO on 2014-06-27. The firm focuses on developing, licensing or acquiring non-implanted technologies targeted at reducing symptoms of neurological disease or trauma. The firm's product, Portable Neuromodulation Stimulator (PoNS), is a non-implanted medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS is used as a short-term treatment of gait deficit due to mild-to-moderate symptoms for multiple sclerosis (MS) and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only. The company is also used as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI) and is to be used in conjunction with physical therapy (PoNS Therapy).

Company Info

HELIUS MEDICAL TECHNOLOGIES

642 Newtown Yardley Road

Newtown PENNSYLVANIA 18940

P: 12159446104.0

CEO: Dane C. Andreeff

Employees: 0

Website: https://heliusmedical.com/

HSDT News

News Image8 days ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Friday morning!

News Image26 days ago - Helius Medical Technologies, Inc.Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial Results

-- Total Q3 revenue up 80% over prior year ---- Cash on hand expected to fund operations through 2023 ---- Company to host call at 8:30am today -- ...

News Image26 days ago - Helius Medical Technologies, Inc.Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial ResultsNews Imagea month ago - Helius Medical Technologies, Inc.Helius Medical Technologies, Inc. Announces Participation of Dr. Prue Plummer and MGH Institute of Health Professions to its Therapeutic Experience Program

-- Fourth Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate impact of subjects’...

News Imagea month ago - Helius Medical Technologies, Inc.Helius Medical Technologies, Inc. Announces Participation of Dr. Prue Plummer and MGH Institute of Health Professions to its Therapeutic Experience ProgramNews Imagea month ago - Helius Medical Technologies, Inc.Helius Medical Technologies, Inc. Announces Participation of Oregon Health & Science University in its Therapeutic Experience Program

-- Third Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate the impact of subjects’...

HSDT Twits

Here you can normally see the latest stock twits on HSDT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example